Journal article

Understanding and preventing type 1 diabetes through the unique working model of TrialNet

Manuela Battaglia, Mark S Anderson, Jane H Buckner, Susan M Geyer, Peter A Gottlieb, Thomas WH Kay, Ake Lernmark, Sarah Muller, Alberto Pugliese, Bart O Roep, Carla J Greenbaum, Mark Peakman

Diabetologia | SPRINGER | Published : 2017

University of Melbourne Researchers

Grants

Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development


Awarded by The Eunice Kennedy Shriver National Institute of Child Health and Human Development


Funding Acknowledgements

The sponsor of the trial was the Type 1 Diabetes TrialNet Study Group. Type 1 Diabetes TrialNet Study Group is a clinical trials network funded by the National Institutes of Health (NIH) through the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Allergy and Infectious Diseases and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (through the cooperative agreements U01 DK061010, U01 DK061034, U01 DK061042, U01 DK061058, U01 DK085465, U01 DK085453, U01 DK085461, U01 DK085466, U01 DK085499, U01 DK085504, U01 DK085509, U01 DK103180, U01 DK103153, U01 DK085476, U01 DK103266, U01 DK103282, U01 DK106984, U01 DK106994, U01 DK107013, U01 DK107014, UC4 DK106993) and JDRF. The content of this review is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or JDRF.